CMV Infection Risk Factors and Viral Dynamics After Valganciclovir Prophylaxis: 10 Years of Experience in Lung Transplant Recipients

CMV Infection Risk Factors and Viral Dynamics After Valganciclovir Prophylaxis: 10 Years of Experience in Lung Transplant Recipients

(1) The prevention of cytomegalovirus (CMV) in lung transplant recipients (LTx) is based on the administration of VGC for a period of 6–12 months, but there is little information on the premature discontinuation of the drug. Our objective was to evaluate the reasons for early cessation of VGC and th...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarela García-Masedo Fernández, Rosalía Laporta, Christian García Fadul, Myriam Aguilar Pérez, Jorge Anel Pedroche, Raquel Sanabrias Fernández de Sevilla, Ana Royuela, Isabel Sánchez Romero, María Piedad Ussetti Gil
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Microorganisms
Subjects:
cytomegalovirus
lung
transplant
valganciclovir
prophylaxis
discontinuation
Online Access:https://www.mdpi.com/2076-2607/12/11/2360
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items